Ignite Creation Date:
2024-05-05 @ 11:27 PM
Last Modification Date:
2024-10-26 @ 10:33 AM
Study NCT ID:
NCT01330771
Status:
COMPLETED
Last Update Posted:
2011-04-07
First Post:
2011-04-06
Brief Title:
Assessment of the Therapeutic Utility of r-FSH in Association With hMG-HP
Sponsor:
Ferring Pharmaceuticals
Organization:
Ferring Pharmaceuticals
Study Overview
Official Title:
Assessment of the Therapeutic Utility of r-FSH in Association With hMG-HP Within a Protocol of Controlled Ovarian Hyperstimulation in IVF in Normoresponders Women Undergoing Downregulation With GnRH Antagonist
Status:
COMPLETED
Status Verified Date:
2011-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To assess the effectiveness of a protocol of ovarian hyperstimulation combining urinary gonadotrophins recombinant gonadotrophins to achieve clinical pregnancy in females undergoing IVF
Study hypothesis to assess the effectiveness of protocols combining urinary gonadotrophins recombinant gonadotrophins
Study hypothesis to assess the effectiveness of protocols combining urinary gonadotrophins recombinant gonadotrophins
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None